No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older
NCT ID: NCT07042139
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
532 participants
INTERVENTIONAL
2025-08-01
2033-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Primary endpoint will be PRWE at 12 months
* Follow-up visits are scheduled at 3 and 12 months. 5-year follow-up will be considered as an exploratory endpoint
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-operative Treatment Versus Volar Locking Plate in Treatment of Distal Radius Fracture in Patients Over 65 Years
NCT02879656
Conservative Treatment of Distal Radius Fracture in Elderly in Randomized Controlled Trial
NCT02894983
Prospective Randomized Comparison of Conservative and Opertaive Treatment of Radius Fractures in Elderly Patients
NCT04655768
Distal Radius Fractures in Patients Over 65 Years, Operation or Cast?
NCT02336035
Cast vs. Splints for Minimally Displaced Distal Radius Fractures in the Elderly
NCT02066857
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
No reduction: In the no reduction group, a dorsal cast is applied to the patient's wrist after the initial radiograph. Following casting, a control radiograph will be taken. Active range of motion exercises for the fingers and light use of the hand are recommended immediately.
Closed reduction: Distal radius fracture reduction is performed in the emergency department under local anaesthetic, with lidocaine infiltrated into the fracture site. Closed reduction is performed by the on-call physician who is responsible for the patient's treatment. Post-reduction radiographs are then taken to assess fracture alignment, although the findings do not influence the treatment of the patient. The follow-up visits, cast removal, and exercise protocol are identical to those inof the no reduction group.
In both groups, the cast will be removed after 5 weeks at either the health center or the hospital's outpatient clinic, in accordance with the local treatment protocol. Following cast removal, patients will be advised to resume everyday use of the injured wrist without restrictions. No radiographs will be taken during the casting period or before the 3-month follow-up.
Observational arm (not part of the randomised equivalence trial): Eligible patients who decline participation in the randomisation will be offered the opportunity to join an observational group. The patients will receive standard care (closed reduction and casting) and will provide consent for follow-up. Reduction of the DRF is performed in the emergency department and post-reduction radiographs will be taken. The observational groups will be treated according to local treatment protocols. Patients in the observational cohort will be followed at the same time points using the same outcome measures as the randomised group. Study follow-up of the observational group will be organized remotely.
Blinding: Recruiting will start at July 2025.Due to the nature of the intervention, the participants will not be blinded. Recruiting personnel will only have access to the randomisation module within the electronic REDCap (Research Electronic Data Capture, https://www.project-redcap.org/) software. The outcome assessors (study nurse or orthopaedic resident or specialist) who collect the baseline data and outcome measures from the follow-up visits will be blinded to the randomisation result. Furthermore, the study personnel involved in the follow-up visits will remain blinded to the randomisation results, as the results will be hidden in REDCap.
Follow-up: Participants will meet a research personnel or coordinator study nurse at the 3-month and 12-month time points. At the 3-month time point, radiographs will be taken. Thereafter, no additional radiographic follow-ups will be organized. Follow-up appointments will be carried out according to the preferences of the participants. For example, all patients will be invited to attend an in-person follow-up visit; however, if this is unsuitable, the follow-up will be conducted remotely via telephone or email link by a blinded study nurse. In the remote option, the accelerometer wristbands will be sent to the participants by regular mail. By offering a remote option, we aim to minimise the number of participants unavailable for follow-up. The participants will receive follow-up questionnaires via email or regular mail prior to their follow-up appointment. If they decline to complete the questionnaires, outcomes will be collected via a telephone interview. The research data will be saved in a database using the online patient management program REDCap. The 5-year follow-up will be conducted by phone.
Rehabilitation: All patients presenting with unsettling symptoms will undergo physiotherapy rehabilitation for up to one year, as in standard care. If the symptoms do not improve during this period, the patient will be referred to an orthopaedic surgeon or hand surgeon for further evaluation where necessary procedures, such as a computed tomography (CT) scan and, in some cases corrective osteotomy, will be considered.
Sample size and power considerations: The sample size was determined based on an equivalence design with an equal allocation ratio (1:1). Based on the MID for PRWE of 11.5 points, the equivalence margin was set at 6 points. This represents the maximum acceptable difference in means between the groups to still be able to consider the groups as equivalent. Based on the findings of previous studies, the standard deviation of the outcome (PRWE) variable was estimated to be 21.9. Using these parameter estimates, a total sample size of 532 participants (266 per group) will provide 90% power to demonstrate equivalence between groups on the primary endpoint, assuming a true mean difference of \< 0.01, a common standard deviation of 21, and equivalence margins of -6 to 6 on the PRWE score. The calculation was based on a 2-sided 90% confidence interval (α = 0.05) and used the exact method for two-sample means under normal distribution assumptions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Closed Reduction
Closed reduction and casting after distal radius fracture
Closed Reduction
Closed reduction
Casting
Dorsal cast
No Reduction
Casting without reduction after distal radius fracture
No reduction
No reduction
Casting
Dorsal cast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No reduction
No reduction
Closed Reduction
Closed reduction
Casting
Dorsal cast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Independent living patients
* Displaced distal radius fracture (AO/OTA 23A/23C) with 15-40 degree dorsal angulation, and/or of shortening of the radius for more than 2 mm.
* Associated ulnar styloid fracture is permitted
* Low energy injury, (fall from \<1 m)
Exclusion Criteria
* Patients who are actively working in a paid position
* Volar angulation, partial articular fractures (AO/OTA 23B)
* Concomitant fracture of the ulna proximal to the base of the styloid process
* Associated fracture or dislocation in any other body part that would affect the use of the injured distal radius
* Distal radius fractures in both arms
* Open injury, Gustilo 2 or higher
* No bony contact between the main fragments
* High energy injuries
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kuopio University Hospital
OTHER
Viborg Regional Hospital
OTHER
Karolinska University Hospital
OTHER
Helsinki University Central Hospital
OTHER
Tartu University Hospital
OTHER
Pori Central Hospital
UNKNOWN
Oulu University Hospital
OTHER
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Kärnä, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Ville Ponkilainen
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Antti Launonen
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Viborg regional Hospital
Viborg, , Denmark
Tartu University Hospital
Tartu, , Estonia
Tampere University Hospital
Tampere, Pirkanmaa, Finland
Helsinki University Hospital
Helsinki, Uusimaa, Finland
Kanta-Häme Central Hospital
Hämeenlinna, , Finland
Kuopio University Hospital
Kuopio, , Finland
Oulu University Hospital
Oulu, , Finland
Pori Central Hospital
Pori, , Finland
Turku University Hospital
Turku, , Finland
Karolinska University Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tina Senholt
Role: backup
Ville Ponkilainen, PhD
Role: backup
Teemu Koivistoinen
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Karna L, Ponkilainen V, Reito A, Ostergaard H, Brorson S, Tootsi K, Paasikallio K, Senholt T, Li Y, Heikkinen J, Kukkonen J, Ryhanen J, Christensen R, Mattila VM, Launonen AP. Effect of no reduction versus closed reduction on distal radius fractures in adults aged 65 years and older: a protocol for the DISCLOSE randomised equivalence trial. BMJ Open. 2025 Oct 16;15(10):e108511. doi: 10.1136/bmjopen-2025-108511.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R25001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.